Phase III Randomized Comparison of Postoperative Adjuvant Chemotherapy with 2-Year Oral UFT (Uracil/Tegafur) versus Six-Cycle CMF (Cyclophosphamide/Methotrexate/5-Fluorouracil) in High-risk Node-Negative Breast Cancer Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.